Compare SOC & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SOC | TOVX |
|---|---|---|
| Founded | 2020 | 2001 |
| Country | United States | United States |
| Employees | 200 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 6.4M |
| IPO Year | N/A | 2012 |
| Metric | SOC | TOVX |
|---|---|---|
| Price | $17.09 | $0.19 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 6.8M | 6.6M |
| Earning Date | 05-08-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 89.07 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $168.46 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.72 | $0.16 |
| 52 Week High | $35.00 | $1.50 |
| Indicator | SOC | TOVX |
|---|---|---|
| Relative Strength Index (RSI) | 70.94 | 48.32 |
| Support Level | $4.27 | $0.17 |
| Resistance Level | $19.99 | $0.26 |
| Average True Range (ATR) | 2.04 | 0.01 |
| MACD | 0.47 | 0.00 |
| Stochastic Oscillator | 81.66 | 26.99 |
Sable Offshore Corp is a Houston-based independent upstream company focused on developing the Santa Ynez Unit in federal waters offshore California. The company operates as one reportable oil and gas segment and is engaged in the acquisition, development, exploration, and production of oil and natural gas.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.